Possible involvement of Copper(II) in Alzheimer disease

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 869-870

  Kowalik Jankowska, Teresa ^a   Ruta Dolejsz, Monika ^a   Wisniewska, Kornelia ^a   Lankiewicz, Leszek ^a   Kozlowski, Henryk ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

Alzheimer disease; Complexes; Copper(II); amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; CHELATING AGENT; COPPER; HYDROXYL RADICAL;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CADAVER; CATALYSIS; CELL AGGREGATION; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; NEUROBIOLOGY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SOLUBILITY;

ANIMALIA;

EID: 0036804346     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5869     Document Type: Article

References (32)

1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Herbert LE, Hennekens CH, Taylor JO. Prevalence of Alzheimer's disease in a community population of older persons. JAMA 262:2551-2556 (1989).
2. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberg F, Grundke-Iqbal I, Iqbal K, Wisniewski HM. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477:90-99 (1989).
3. Masters CL, Simms G, Weinman A, Multhaup G, McDonald BL, Beyreuther K. Amyloid plague core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249 (1985).
4. Esch F, Keim PS, Beattie EC, Blacher RW, Culwell AR. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1128 (1990).
5. Yamada T, Sasaki H, Furuya H, Miyata T, Goto I, Sakaki Y. Complementary DNA for the mouse homolog of the human amyloid β protein precursor. Biochem Biophys Res Commun 149:665-671 (1987).
6. Otvos LJ, Szendrei GI, Lee VM, Mantsch HH. Human and rodent Alzheimer β-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur J Biochem 211:249-257 (1993).
7. Joachim CL, Selkoe DJ. The seminal role of β-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoic Disord 6:7-34 (1992).
8. Price DL, Sisodia SS. Cellular and molecular biology of Alzheimer's disease and animal models. Annu Rev Med 45:435-446 (1994).
9. Blush AI. Metals and neuroscience. Curr Opin Chem Biol 4:184-191 (2000).
10. Camakaris J, Voskoboinik I, Mercer JF. Molecular mechanisms of copper homeostasis. Biochem Biophys Res Commun 261:225-232 (1999).
11. Linder MC. Biochemistry of Copper. New York:Plenum Press, 1991.
12. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158:47-52 (1998).
13. Atwood CS, Huang X, Moir RD, Tanzi RE, Bush AI. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met Ions Biol Syst 36:309-364 (1999).
14. Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, Beyreuther K, Tanzi RE, Masters CL, Bush AI. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem 274:23223-23228 (1999).
15. Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271:1406-1409 (1996).
16. Ruiz FH, Gonzalez M, Bodini M, Opazo C, Inestrosa NC. Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein. J Neurochem 73:1288-1292 (1999).
17. Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Bill E, Pipkorn R, Masters CL, Beyreuther K. Copper binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 37:7224-7230 (1998)
18. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83-106 (1996).
19. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 90:2092-2096 (1993).
20. Cappai R, White AR. Amyloid β. Int J Biochem Cell Biol 31:885-889 (1999).
21. Howlett DR, Jennings KH, Lee DC, Clark MSG, Brown F, Wetzel R, Wood SJ, Camilleri P, Roberts GW. Aggregation state and neurotoxic properties of Alzheimer β-amyloid peptide. Neurodegeneration 4:23-32 (1995).
22. Cherny RA, Atwood CS, Xilinos ME, Gray DN, Jones WD, McLean CA. Barnham KJ, Volitakis J, Fraser FW, Kim Y, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30:665-676 (2001).
23. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra ME, Romano DM, Hartshorn MA, Tanzi RE, Bush AI. Dramatic aggregation of Alzheimer Aß by CU(II) is induced by conditions representing physiological acidosis. J Biol Chem 273:12817-12826 (1998).
24. Liu ST, Howlett G, Barrow CJ. Histidine-13 is a crucial residue in the zinc ion induced aggregation of the Aβ peptide of Alzheimer's disease. Biochemistry 38:9373-9378 (1999).
25. Miura T, Suzuki K, Kohata N, Takeuchi H. Metal binding modes of Alzheimer's amyloid β-peptide in insoluble aggregates and soluble complexes. Biochemistry 39:7024-7031 (2000).
26. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi ER, Bush AI. Characterization of copper interactions with Alzheimer amyloid ß peptides: identification of an attomolar-affinity copper binding site on amyloid β 1-42. J Neurochem 75:1219-1233 (2000).
27. Silva JRRED, Williams RJP. The Biological Chemistry of the Elements: The Inorganic Chemistry of Life. Oxford:Clarendon Press, 1991.
28. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38:7609-7616 (1999).
29. Kowalik-Jankowska T, Ruta-Dolejsz M, Wisniewska K, Lankiewicz L. Cu(II) interaction with N-terminal fragments of human and mouse β-amyloid peptide. J Inorg Biochem 86:535-545 (2001).
30. Kowalik-Jankowska T, Ruta-Dolejsz M, Wisniewska K, Lankiewicz L, Kozlowski H. Copper(II) complexation by human and mouse fragments (11-16) of β-amyloid peptide. J Chem Soc Dalton Trans (3):4511-4519 (2000).
31. Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 62:797-821 (1993).
32. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 71(suppl):621S-629S (2000).